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Abstract
As the frequency and duration of space travel increase, the potential need for emergency medical care
in space grows, and with it the need for patient monitoring devices supporting therapeutic treatment.
Providing emergency care to an injured astronaut may necessitate immediate surgery. During such events,
the timely administration of anesthetic agents will need to be performed by someone who is not a formally
trained anesthesiologist. The availability of usable real-time displays of intravenous anesthetic
concentrations and effects could significantly enhance intraoperative clinical decision-making both in space
and on earth. The effectiveness of the real-time anesthesia display on the management of total intravenous
anesthesia was determined by 31 anesthesiologists participating in a simulation study. In the presence of
the anesthesia drug display, clinicians maintained physiologic indicators such as blood pressure and heart
rate closer to baseline levels. Participants also reported an increase in perceived performance when using
the drug display. The results indicate that surgeries on earth and in orbit would benefit from the
implementation of this display.

Introduction
Monitoring devices that show intravenous (IV)
drug concentrations and effects currently do not
exist in space or in the modem operating room.
However, the pharmacokinetic and
pharmacodynamic models are available to estimate
past, present and future effect site drug
concentrations and associated physiological effects.
An interdisciplinary research team (bioengineering,
architecture, clinical anesthesia, and cognitive
psychology) developed a graphic display that
shows the predicted concentrations of intravenous
drugs in real-time.

During surgery, levels of sedation, analgesia
and neuromuscular blockade are controlled by the
timely administration of anesthetic drugs. Drugs
are titrated while vital signs are monitored. The
patient's response is observed until the desired
effects are achieved. Compared with the
administration of volatile anesthetics, this task is
more demanding for increasingly popular IV
anesthesia since drug plasma or effect site
concentrations cannot be easily measured in realtime. Accurate administration of anesthetic agents
could also be further complicated in a zero gravity
environment.

Figure 1: The drug display showing drug doses, predicted effect site concentrations and predicted effects on
sedation, analgesia and neuromuscular blockage. The three plots show trends (solid lines) and predictions
(dashed lines) for the modeled effect site concentrations for the three classes of drugs. The current effect
site concentrations are seen at time zero (just to the right of the middle of the display). Past history moves
to the left of time zero (to -30 min) and the predicted future levels move to the right (to +10 min). The bar
graphs on the far right show the combined effects of all drugs administered on sedation, analgesia, and
neuromuscular blockade.
the-art pharmacokinetic and pharmacodynamic
models. The value of the prototype display to
clinicians was assessed favorably as they delivered
bolus doses of remifentanil and propofol using a
software based patient simulator. 3 Results from
this study led our development group to alter the
prototype design in an effort to further improve
performance.
The new display (see Figure 1) can predict
values for drugs administered in isolation and also
when multiple drugs of the same class are used.
Some drugs combined synergistic effects. Multiple
drug effects and their interactions within a class
and also between classes are also displayed. The
information presented to the anesthesiologists is
mapped to clinically relevant information rather
than an arbitrary scale from zero to 100%.

Multi-compartment pharmacokinetic models
and their pharmacodynamic relationships have been
developed that predict the arterial plasma and effect
site concentrations for many intravenous
anesthetics, analgesics, and neuromuscular
blocking agents. These models permit the
calculation of effect-site concentration for each
agent, using iterative difference equations. \; 2
When a bolus of drug is administered, the
pharmacokinetic model can provide a prediction of
the resulting effect site concentration. The modelbased predictions should provide a guide to drug
administration resulting in better control of plasma
drug concentrations.
Our research group at the University of Utah
developed and tested a prototype of a continuous
display design containing predicted effect site
concentrations and drug effects based on state-of-
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Figure 2: Consciousness levels change with the predicted level of sedation. The OANS curve is drawn
from the 5th to the 95 th percentile. Below the 95 th percentile, the patient's eyelids are open and the
respiratory rate is 12 breaths/min. As the sedation level continues to increases above the 95 th percentile, the
patient's eyelids close and the respiratory rate falls to 6 and then to 0 breaths/min.
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Figure 3: The drug level (effect-site concentration) for Analgesia. The fIrst curve corresponds to mild
surgical stimuli and the second curve applies to laryngoscopy. When analgesia levels exceed the area under
the curve the patient has sufficient analgesia for the type of stimulus.
wake up time and duration of anesthetic should all
be reduced in the display condition. A further
hypothesis predicts that NASA-TLX workload
assessments 4 would also indicate an overall
reduction in perceived workload associated with
improved performance. Additionally subjects
should continue to subjectively rate the display
favorably.
The experimental task was made challenging
by changing the needs of the surgeon, and thus the
demands of anesthesia, midway through the
simulated surgical procedure. As levels of painful
stimulus change, anesthesiologists using the drug
display should be better able to manage the
changing needs of the patient relative to the control
group. Additionally anesthesiologists were asked
to care for their patient in a METI high fIdelity
simulator environment

Examples of other changes made to the display are
shown in Figures 2 and 3. Figure 2 shows the
effect site concentration window for the sedative
class of drugs as produced in the current iteration
of the display. Within the effect site concentration
window for sedatives the Observer's Assessment of
Awake or Asleep Scale (OAAJS) sigmoidal
function has been added to indicate the range of
drug level to necessary to anesthetize 95% of the
population.
In Figure 3, the analgesic effect site
concentration is shown. Within this display
window sigmoidal curves indicate the level of
analgesia relative to mildly painful surgical stimuli
such as skin incision and severe surgical stimuli
such as laryngoscopy. When the level of analgesia
exceeds the area under the curve, the amount of
analgesic is suffIcient to block pain for 95% of the
population. Other changes include the mapping of
the neuromuscular blockade effect site
concentration to the train of four stimulus. The
amount of neuromuscular blockade on board as
shown in the display predicts accurately the amount
of paralysis for 95% of the population. After these
and other changes in the arrangement of
information in the display, we tested the new
iteration of the display design on a sample of
anesthesiologists.
In this study we test the hypothesis that
pharmacodynamic models which predict levels of
sedation, analgesia and neuromuscular blockade,
help the clinician to choose the optimum
combinations of drugs; thus maximizing the desired
therapeutic effects while minimizing adverse side
effects. The new display should be able to help the
anesthesiologist maintain levels of sedative,
analgesic and neuromuscular blocking agents at
levels appropriate for the changing demands of the
surgical procedure relative to a control condition
performing without the display. Pain response,

Methods
Subjects
Thirty-one anesthesiologists and anesthetists with a
range of clinical experience (CRNA, CA-2 and
CA-3, and faculty) participated in this study. All
participants were paid $50.00 for their participation
in the study. All participants were affiliated with
the University of Utah School of Medicine.
Procedure
Upon arriving at the Center for Patient
Simulation, subjects completed a questionnaire to
elicit their experience level, length of time working
prior to the study, caffeine consumption, sleep
history, color-vision, and whether they required
vision correction. Subjects were instructed to
provide anesthesia to a simulated patient during
surgery using the total intravenous anesthesia
method (TIVA). A standardized training (see
below) followed where all participants were trained
in the use of the drug display, instructed in the use
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Figure 4. Outline of painful surgical stimulus
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Figure 4: Diagram of the surgical procedure as a function of painful stimuli and time. Participants were
required to administer appropriate analgesic and sedative for the changing dynamics of the surgical
procedure.
of the METI simulator, and the equipment used for
the delivery of the drugs.
Prior to beginning the simulation, participants
reviewed the anesthesia record and patient
information sheet providing them with medical
information about the patient, including allergies
and experienced past problems, and the planned
procedure. Subjects then began to induce
anesthesia, intubate the patient's trachea, and
provide care for the simulated patient throughout a
shoulder endoscopy procedure. Seventeen minutes
into the endoscopy the surgeon announced that the
originally planned scope procedure was not
sufficient to repair the damaged shoulder, and that
a more invasive Bankart procedure would need to
be performed. The change in surgical procedure
significantly altered the requirements for the
delivery of anesthetics and the projected time
requirements for the surgery (See Figure 4). After
providing care for the duration of the surgical
procedure the anesthesiologist extubated the patient
and waited until the patient regained consciousness.
After completing the simulation, the subjects
answered a NASA-TLX questionnaire and a
questionnaire about the drug display and the
realism of the simulation. The experimental
session lasted approximately ninety minutes, and
the subjects were debriefed and compensated $50
for their participation.

Aparati
The MET! anesthesia simulator (MET!,
Sarasota, FL.) at the University of Utah Center for
Patient Simulation was used to conduct the
simulation. An AS/3 anesthesia monitor (Datex,
Helsinki, Finland) displayed the traditional
electrocardiogram (ECG), arterial blood pressure
(BP), pulse oximeter (Sp02), and capnogram
(C02) waveforms. Digital values for heart rate
(HR), blood pressure (BP), oxygen saturation
(Sp02), end-tidal carbon dioxide (FetC02), and
fraction of inspired oxygen (Fi02) were displayed
in addition. The pulse oximeter tone was also
provided. Alarms were set to default mode. The
drug display (Figure 1) was shown on a 17-inch
monitor placed beside the AS/3 monitor.
Training
A computerized tutorial was presented to each
subject in order to provide standardized training in
use of the drug display for all subjects. Subjects
viewed static screen shots of the drug display
monitor depicting the effect site concentrations and
current effects of propofol, remifentanil, fentanil,
and rocuronium on sedation, analgesia and
neuromuscular blockade. The display was
explained in detail including: axes, labels, drug
classifications, effect site concentrations according
to clinically relevant variables, the effect bars,
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effect site concentration and its relation to drug
effect, predicted, past, and present concentrations.
The participants were told the display shows
estimated effect site concentrations and drug effects
generated from pharmacodynamic models.
A minimum amount of training was required
for the METI high fidelity simulator because most
subjects were familiar with the simulator from
previous exposure as part of their anesthesia
training. All subjects were instructed in the use of
the drug delivery systems. To demonstrate
proficiency in use of the drug delivery system, each
subject administered a fixed infusion rate and a
specified bolus dose as practice. Training for the
simulator was completed when the subject reported
feeling comfortable with administration of the
anesthetic agents in the simulated patient. On
average, the training took 20 minutes. Half of the
subjects were then assigned randomly to the drug
display condition and the remaining half were
assigned to the control condition.

effect site concentrations of all administered drugs
were recorded at two-second intervals. The time
duration from completion of skin closure to
awakening (spontaneous respiration and eyes
opening) and extubation were recorded.
Data Analysis
Pain Response
The goal during the surgery is to keep the vital
signs as stable as possible, reducing patient risk.
Thus the dependent measures for the difficult to
manage Bankhart procedure were analyzed.
Performance in analgesia management was
measured by comparing the pharmacodynamic
predicted level of analgesia with the level of
surgical stimulation (Figure 4). Since the simulator
was calibrated such that cardiovascular responses
matched the pharmacodynamic predictions,
subjects with and without the drug display had the
same cardiovascular information available. Heart
rate (HR) and mean arterial blood pressure (MAB)
were used to measure periods when the patient
responded adversely to pain.

Surgical Scenario
Prior to starting the simulation, the subjects
were given the patient's preanesthetic evaluation
form including: the patient's medical and surgical
history, labs, baseline vital signs, planed surgical
procedure, and the expected duration of the
surgery. The patient was presented as having
arrived in the operating room without prior
sedation or pre-oxygenation; however, ECG
electrodes, an IV, an arterial line, and a noninvasive blood pressure cuff were already in place.
The anesthesiologist was told the patient was
scheduled to receive a routine shoulder endoscopy
to repair minor damage, a procedure usually lasting
about 25 minutes. The subject was reminded that
he or she may administer boluses or continuous
infusions of propofol and remifentanil, as well as
bolus doses of fentanyl and rocuronium. Antagonist
drugs and other cardiovascular agents were not
available for use. The subject was given a new
anesthetic record and was reminded to keep the
record during the course of the simulation

Wake Up Time
To determine the time it took to wake the
patient up, we measured the time between skin
closure and the time when the patients eyes opened
and had a respiratory rate of 6 breath per minute.
Total Time
The time for patient emergence was measured
by determining the time between induction of
anesthesia (the time of eye closure and respiratory
rate of zero) and the patients eye-opening and
return of the respiratory rate to 6 breath per minute.
Questionnaires
The mean and standard deviations of the
scores were computed for the participants' answers
to the NASA-TLX workload survey and the first
question of the evaluation questionnaire regarding
display usefulness. Ratings pertaining to the
realism of the simulated surgery were also solicited.

Data Collection
During the simulated surgery, predicted effect
site concentrations of all administered drugs and
model predicted levels of sedation, analgesia, and
NMB were recorded. Patient vital signs were also
recorded during the surgery. Minimum, maximum,
mean, and percent deviations from baseline were
calculated for heart rate, systolic, diastolic and
mean blood pressure. The values of the vital signs
were recorded at four-second intervals and the

Pain Response
Overall analyses of pain response during the
Bankhart procedure (unexpected and requiring
changes in the anesthesia plan) indicate
performance differences observed were due to the
presence of the drug display. When
anesthesiologists were using the drug display, their
level of performance was higher indicated by
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T able I P am
. R esponse
Drug display Control
65.4 (12.4)
57.4 (14.1)
90.1 (19.8)

T able 2 W ake UJP Tillle
Drug
Control
display
Opening eyes
736 (160) 862 (176)

79.6 (17.8)

Respiration 50%

1.2 (1.4)
Pain score
.67 (Ll)
Table 1. Means (standard deviations) for heart
rate, mean arterial blood pressure, pain scores
during the Bankhart procedure.

577 (148)

774 (176)

Table 2. Tillle (standard deVIatIOns) m seconds
during the wake up time interval and recovery of
respiratory rate to 50% of baseline.

higher mean arterial blood pressure, higher heart
rate, and lower pain levels than the performance of
the control group (See Table 1).
As painful stimuli occur, the associated pain
score (0-10) is compared with the predicted
analgesic level (0-10). If the level of analgesia is
below the pain score, the cardiovascular variables
increase above baseline simulating a cardiovascular
response. If the level of analgesia is higher than the
pain score, the cardiovascular variables are lower
than baseline.
Analyzing the patient's heart rate during the
Bankhart procedure revealed a main effect of
display condition (F(I,25)=4.87; p=.037), with
average heart rate closer to baseline when subjects
were using the drug display.
Analyzing the mean arterial blood pressure
during the Bankhart procedure showed that subjects
in the drug display condition were able to keep the
blood pressure of the patient closer to baseline
levels than anesthesiologists who were in the
control group (F(I,25)=4.379;p=.047).
Analyzing the level of control for pain showed
a similar picture as the analyses of heart rate and
mean arterial blood pressure. Again, there is a
reliable difference between the display condition
and the control condition (F(I,25)=5.507;p=.027),
with lower levels of pain in the group where
anesthesiologists were using the drug display.

treated by an anesthesiologist in the drug display
condition. These results indicate there was a strong
effect of the display condition on performance.
Shorter wake up latencies were observed and
respiratory rate returned to normal more quickly
when the patient was treated by an
anesthesiologists using the drug display.
Total Time
Another way to analyze the performance in
terms of the quality of delivering anesthesia is to
look at the overall duration of the procedure. Since
the surgical portion of the procedure was consistent
between subjects, the differences in total time can
be attributed to display condition. The data were
analyzed by using the total time for the surgical
procedure from the beginning of the preoperative
phase to the point of extubation of the patient. The
ANOVA revealed a main effect of condition
(F(1 ,30)=4.73 ; p=.039), with anesthesia being
delivered more efficiently when patients were
treated by anesthesiologists using the drug display
(see Table 3). The results again indicate there was
a strong effect of the display condition on
performance. Shorter procedure durations were
observed when the anesthesiologists used the drug
display.
Questionnaire data
The analyses of the NASA TLX revealed a
reliable difference between conditions in terms of
subjective performance (F(I ,30)=4.44; p=.045).
Subjects who were using the drug display rated

Wake Up Time
The same design as described above was used
to analyze the time for emergence from anesthesia
(see Table 2). Analyzing the time until eye
opening showed a significant main effect of
condition (F(I ,29)= 4.26; p=. 05). Patients who
were treated in the drug display condition woke up
more than two minutes earlier than patients treated
without using the drug display.
Analyzing the time for respiratory rate
reaching the criterion of 50% of the baseline level
shows a main effect of condition (F(1,29)=11.39;
p=.003) with patients reaching this respiratory rate
more than three minutes faster when they were

Table 3 Total Time
Drug
Control
display
Total time for
procedure

2826 (542)

3215 (640)

{4 7 minutes} {54 minutes}
Table 3. Total procedure tIme m seconds (standard
deviation) for the drug display and the control
condition. Below is the total time in minutes.
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